SF20 Human

Chromosome 19 Open Reading Frame 10 Human Recombinant
Shipped with Ice Packs
In Stock

Description

SF20 Human Recombinant produced in E.Coli is single, a non-glycosylated, Polypeptide chain containing 162 amino acids fragment (33-173) and having a total molecular mass of 18 kDa. C9orf10 is fused to 20 amino acids His tag at N-terminus and is purified by proprietary chromatographic techniques.

Product Specs

Introduction
The interleukin SF20 is believed to be involved in the multiplication of lymphoid cells. Initially, it was discovered as a substance produced by stromal cells in the bone marrow.
Description
Produced in E. coli, Recombinant Human SF20 is a single, non-glycosylated polypeptide chain. It consists of 162 amino acids (fragment 33-173), resulting in a molecular mass of 18 kDa. The protein, also known as C9orf10, is fused to a 20 amino acid His tag at its N-terminus and undergoes purification using proprietary chromatographic methods.
Physical Appearance
A clear solution that has been sterilized by filtration.
Formulation
C9orf10 is provided in a solution containing 20mM Tris HCL at a pH of 8 and 20% glycerol.
Stability
For optimal storage, keep the entire vial at 4°C if it will be used within 2-4 weeks. For extended storage, freeze at -20°C. Repeated freezing and thawing should be avoided.
Purity
SDS-PAGE analysis indicates a purity exceeding 95.0%.
Synonyms
C19orf10, Interleukin-25, IL-25, IL25, IL27, IL-27, IL27w, IL-27w, Stromal cell-derived growth factor SF20, UPF0556 protein C19orf10, chromosome 19 open reading frame 10.
Source
Escherichia Coli.

Q&A

What is experimental design in human research and why is it important?

Experimental design refers to the framework used to test hypotheses by manipulating one or more variables and observing their effects. In human research, proper experimental design is essential for:

  • Establishing cause-and-effect relationships

  • Controlling for extraneous variables

  • Ensuring reliability and validity of findings

  • Meeting ethical standards for human subject protection

Experimental design allows researchers to make valid inferences by systematically manipulating independent variables while controlling for potential confounders. This structured approach helps isolate the effects of specific factors on outcomes of interest, which is particularly important in complex human research scenarios .

The fundamental elements of experimental design include:

ComponentDescription
Independent VariablesFactors manipulated by researchers (e.g., treatment conditions)
Dependent VariablesOutcomes measured to assess effects of manipulation
Control VariablesFactors kept constant to isolate effects of interest
RandomizationProcess of randomly assigning participants to conditions
ReplicationRepeating experiments to verify findings

How do I identify and control for extraneous variables in human research?

Identification methods:

  • Literature review to identify previously documented confounders

  • Pilot testing to detect unexpected influencing factors

  • Expert consultation to leverage field-specific knowledge

  • Theoretical analysis of potential causal pathways

Control strategies:

  • Randomization: Random assignment of participants to conditions helps distribute unknown extraneous variables equally across groups

  • Matching: Pairing participants with similar characteristics across different experimental conditions

  • Statistical control: Measuring potential confounders and including them as covariates in analysis

  • Experimental control: Standardizing procedures, environment, and instructions

  • Blocking: Grouping similar participants together before randomization to reduce within-block variability

For example, in a study investigating cognitive performance under different environmental conditions, researchers might control for participants' baseline cognitive abilities, age, educational background, and time of day when testing occurs to isolate the effects of the environmental manipulation.

The effectiveness of these control strategies depends on the specific research context and the nature of potential confounders. The most robust designs often employ multiple control strategies simultaneously .

What are the key ethical considerations when designing human research studies?

Human research must adhere to strict ethical standards to protect participants' rights, dignity, and welfare. The International Compilation of Human Research Standards enumerates over 1,000 laws, regulations, and guidelines governing human subject protections across 133 countries .

Core ethical principles:

  • Respect for persons: Recognizing participant autonomy and protecting those with diminished autonomy

  • Beneficence: Maximizing benefits while minimizing harm

  • Justice: Ensuring fair distribution of research benefits and burdens

Essential ethical requirements in study design:

RequirementMethodological Implementation
Informed consentDevelop clear, comprehensive consent documents; ensure understanding; document consent process
Risk minimizationDesign procedures to minimize physical, psychological, social, and economic risks
Privacy protectionImplement data security measures; limit identifiable information collection; plan for secure data storage
Vulnerable population safeguardsApply additional protections for children, prisoners, pregnant women, and those with diminished capacity
Equitable selectionDevelop inclusive recruitment strategies without targeting vulnerable groups for convenience

The U.S. regulations provide specific additional protections for certain vulnerable populations:

  • Subpart B: Pregnant women, human fetuses, and neonates

  • Subpart C: Prisoners

  • Subpart D: Children

  • Subpart E: IRB registration requirements

Researchers must integrate these ethical considerations into their study design from the outset rather than treating them as administrative hurdles to overcome. Well-designed studies balance scientific rigor with robust ethical protections .

How do different experimental design types affect causal inference in human research?

The strength of causal inference varies considerably across different experimental design types. Understanding these differences is critical for selecting the appropriate design and correctly interpreting results.

True experimental designs provide the strongest basis for causal inference due to:

  • Random assignment of participants to conditions

  • Researcher control over the independent variable

  • Presence of appropriate control or comparison groups

These designs include randomized controlled trials, factorial designs, and randomized block designs .

Quasi-experimental designs offer more limited causal inference because they lack randomization:

  • Non-equivalent group designs

  • Interrupted time series designs

  • Regression discontinuity designs

These designs are valuable when randomization is impossible or unethical but require additional methodological safeguards to strengthen causal claims .

Pre-experimental designs provide the weakest basis for causal inference:

  • One-shot case studies

  • One-group pretest-posttest designs

  • Comparisons with uncontrolled group membership

These designs are primarily useful for generating hypotheses rather than testing them .

The following table compares the strength of causal inference across design types:

Design TypeRandomizationControl GroupThreats to Internal ValidityCausal Inference Strength
True ExperimentalYesYesMinimizedStrong
Quasi-ExperimentalNoYesModerateModerate
Pre-ExperimentalNoOften NoHighWeak

Researchers should select the strongest design feasible given practical and ethical constraints, while transparently acknowledging limitations in causal inference when using less robust designs .

How can researchers effectively address conflicting findings in lipoprotein metabolism studies?

Conflicting findings in lipoprotein metabolism research present significant challenges for researchers. A methodological approach to addressing these contradictions includes:

1. Systematic examination of methodological differences:

  • Analytical techniques (e.g., ultracentrifugation vs. electrophoresis)

  • Model systems (human vs. animal models such as cynomolgus monkeys)

  • Experimental conditions (fasting state, timing, antibody specificity)

  • Sample populations and their characteristics

For example, research on hepatic triglyceride lipase activity showed that antisera produced against human postheparin hepatic lipase fully inhibited cynomolgus monkey postheparin plasma hepatic triglyceride lipase activity but did not inhibit lipoprotein lipase activity .

2. Integration of contradictory findings:

  • Meta-analysis of quantitative results across studies

  • Development of more comprehensive models that accommodate apparently contradictory results

  • Exploration of moderator variables that might explain differences

3. Design of critical experiments:

  • Studies specifically designed to test competing hypotheses

  • Replication with methodological variations to identify sources of discrepancy

  • Collaboration between labs with contradictory findings

4. Advanced analytical approaches:

  • Sensitivity analyses to determine how robust findings are to methodological variations

  • Bayesian methods to incorporate prior knowledge and uncertainty

  • Individual patient data meta-analysis when raw data are available

For instance, in lipoprotein metabolism research, contradictions regarding lipase activity effects on lipoprotein profiles might be resolved by carefully controlling for species differences, antibody specificity, and analytical methods for measuring lipoprotein fractions .

What methodological approaches can improve replicability in human research studies?

Enhancing replicability in human research requires systematic methodological approaches across the research lifecycle:

Study design phase:

  • A priori power analysis: Ensure adequate sample size to detect effects of interest

  • Pre-registration: Document hypotheses, methods, and analysis plans before data collection

  • Standardization: Develop detailed protocols for all procedures

  • Pilot testing: Identify and address methodological issues before full implementation

Measurement considerations:

  • Validated instruments: Use measures with established reliability and validity

  • Multiple measurements: Employ different measurement approaches for key constructs

  • Standardized conditions: Control environmental factors during data collection

  • Calibration: Regularly verify measurement equipment accuracy

Analysis practices:

  • Pre-specified analyses: Follow registered analysis plans

  • Comprehensive reporting: Report all analyses conducted, including "unsuccessful" ones

  • Effect size reporting: Focus on magnitude of effects and confidence intervals, not just p-values

  • Open data and code: Share data and analysis scripts to enable verification

Replication strategies:

TypeDescriptionWhen to Use
Direct replicationExact repetition of original study proceduresTo verify specific findings
Conceptual replicationTesting same hypotheses with different methodsTo assess generalizability
Systematic replicationVarying specific aspects methodicallyTo identify boundary conditions
Multisite replicationConducting identical protocols across locationsTo assess site-specific effects

Implementing these methodological approaches can substantially improve the replicability of human research findings, advancing scientific knowledge more effectively and efficiently .

What international standards govern human research, and how do they vary across countries?

Human research is governed by a complex network of international, regional, and national standards that researchers must navigate. The International Compilation of Human Research Standards documents over 1,000 laws, regulations, and guidelines across 133 countries .

Key international frameworks:

  • Declaration of Helsinki (World Medical Association)

  • International Council for Harmonisation (ICH) Good Clinical Practice

  • UNESCO Universal Declaration on Bioethics and Human Rights

  • Council for International Organizations of Medical Sciences (CIOMS) Guidelines

Categories of research standards:

CategoryDescriptionExamples
GeneralApplicable to most human researchCommon Rule (US), Tri-Council Policy Statement (Canada)
Drugs, Biologics, and DevicesSpecific to medical product researchFDA regulations (US), EMA guidelines (EU)
Clinical Trial RegistriesRequirements for study registrationClinicalTrials.gov, EU Clinical Trials Register
Research InjuryCompensation for research-related harmsNational compensation schemes, insurance requirements
Social-Behavioral ResearchSpecific to non-biomedical researchSpecialized ethical frameworks for behavioral studies
Privacy/Data ProtectionGoverning research data managementGDPR (EU), HIPAA (US), Privacy Act (US)
Human Biological MaterialsStandards for specimen collection/useBiobank governance frameworks, consent requirements
GeneticRegulations for genetic researchCountry-specific genetic research policies
Embryos, Stem Cells, and CloningOversight of specialized research areasVaried national policies on permissibility and oversight

Regional variations:
Standards vary significantly in stringency, scope, implementation, and enforcement. For international research, investigators must typically comply with the most stringent applicable requirements across all participating sites .

For example, the U.S. has specific regulatory subparts providing additional protections for vulnerable populations (pregnant women, fetuses, neonates, prisoners, and children), while other countries may have different approaches to protecting these groups .

How should researchers approach privacy and data protection requirements in human studies?

Privacy and data protection have become increasingly complex aspects of human research compliance, with significant methodological implications for study design and implementation.

Key privacy frameworks affecting research:

  • Health Insurance Portability and Accountability Act (HIPAA) in the US

  • General Data Protection Regulation (GDPR) in Europe

  • Privacy Act in the US and similar national legislation elsewhere

  • Country-specific data protection laws and regulations

Methodological approaches to privacy compliance:

  • Data minimization: Collect only data necessary for research objectives

    • Review each data element for scientific necessity

    • Avoid collecting identifying information unless essential

    • Consider using aggregate or de-identified data when possible

  • Technical safeguards:

    • Encryption for data at rest and in transit

    • Access controls based on the principle of least privilege

    • Secure computing environments for sensitive data analysis

    • Regular security assessments and updates

  • Consent and transparency:

    • Develop clear, specific privacy notices

    • Obtain explicit consent for data collection, use, and sharing

    • Implement processes for participants to exercise data rights

    • Document compliance with applicable regulations

  • Data lifecycle management:

    • Establish retention policies aligned with regulatory requirements

    • Implement secure destruction procedures

    • Maintain audit trails of data access and use

    • Plan for secure transfer to repositories or archives

The requirements for privacy and data protection vary based on:

  • Research context and setting

  • Types of data collected (especially sensitive categories)

  • Funding sources and applicable regulations

  • International collaborations spanning multiple jurisdictions

Researchers should incorporate privacy by design principles from the earliest stages of protocol development rather than addressing privacy as an afterthought.

What special methodological considerations apply to research involving vulnerable populations?

Research involving vulnerable populations requires specialized methodological approaches to ensure both scientific validity and ethical conduct. The U.S. regulations include specific subparts for additional protections for vulnerable groups:

  • Subpart B: Pregnant women, human fetuses, and neonates

  • Subpart C: Prisoners

  • Subpart D: Children

Methodological considerations across vulnerable populations:

  • Scientific necessity: Justify inclusion based on research objectives

    • Demonstrate why the research questions must be addressed in the vulnerable population

    • Explain why results from non-vulnerable populations would be inadequate

  • Risk minimization strategies:

    • Modify standard protocols to accommodate vulnerabilities

    • Develop monitoring plans specific to anticipated risks

    • Implement stopping rules based on population-specific safety thresholds

  • Consent adaptations:

    • Design processes appropriate to decisional capacity

    • Develop simplified materials for those with limited literacy or comprehension

    • Implement ongoing consent verification when appropriate

    • Utilize legally authorized representatives when necessary

  • Privacy enhancements:

    • Apply additional confidentiality protections

    • Consider implications of mandatory reporting requirements

    • Address group harms and stigmatization risks

Population-specific methodological approaches:

Vulnerable GroupKey Methodological Considerations
ChildrenAge-appropriate assent processes; developmental assessment tools; parent/guardian permission; pediatric-specific risk assessment
PrisonersProcedures to minimize coercion; equity in research benefits; privacy in correctional settings; follow-up plans for transitioning participants
Pregnant womenFetal risk assessment; maternal-fetal risk balance; reproductive toxicity expertise on review committees; long-term follow-up planning
Cognitively impairedCapacity assessment protocols; surrogate decision-maker processes; simplified consent materials; additional safeguards against exploitation

These methodological approaches should be integrated into the research design from inception rather than added as afterthoughts, ensuring both scientific rigor and ethical compliance .

What statistical approaches are most appropriate for analyzing human lipoprotein metabolism data?

Analysis of lipoprotein metabolism data presents unique statistical challenges due to the complexity of lipid metabolism pathways, individual variability, and the interconnected nature of lipid fractions. Based on research methodologies in the field, several statistical approaches are particularly valuable:

1. Multivariate analysis techniques:

  • Principal Component Analysis (PCA) to identify patterns in lipoprotein profiles

  • Partial Least Squares (PLS) regression for modeling relationships between lipoproteins and metabolic factors

  • Cluster analysis to identify subgroups with similar lipoprotein patterns

2. Repeated measures approaches:

  • Mixed-effects models to account for within-subject correlations in longitudinal studies

  • Area Under the Curve (AUC) analysis for time-course data (e.g., postprandial lipid responses)

  • Time series analysis for dynamic changes in lipoprotein metabolism

3. Specialized techniques for lipoprotein research:

  • Kinetic modeling of lipoprotein metabolism using compartmental analysis

  • Isotope dilution methodologies for turnover studies

  • Fractional catabolic rate calculations

For example, in research examining hepatic triglyceride lipase activity in cynomolgus monkeys, analysis focused on quantitative changes in lipoprotein fractions isolated by ultracentrifugation before and after antibody infusion. This approach allowed researchers to observe that hepatic triglyceride lipase inhibition led to increases in very low density lipoproteins (Sf 20-400) and intermediate density lipoproteins (Sf 12-20) .

When analyzing complex lipoprotein data, researchers should consider:

  • Non-normal distributions often observed in lipid measurements

  • Potential for complex interactions between metabolic pathways

  • Need to account for fasting status and dietary influences

  • Importance of between-subject variability in metabolic response

How can researchers effectively design experiments to isolate specific enzyme effects in metabolism studies?

Designing experiments to isolate specific enzyme effects in metabolism studies requires sophisticated methodological approaches, particularly when studying complex systems like lipoprotein metabolism:

1. Selective inhibition strategies:

  • Use of specific antibodies to inhibit target enzymes

  • Application of pharmaceutical inhibitors with known selectivity

  • Genetic approaches (knockouts, knockdowns, or overexpression)

For example, researchers investigating hepatic triglyceride lipase used antisera produced against human postheparin hepatic lipase to selectively inhibit this enzyme in cynomolgus monkeys. This approach confirmed the antibody's specificity by demonstrating it inhibited hepatic triglyceride lipase activity without affecting lipoprotein lipase activity .

2. Experimental design considerations:

  • Controlled baseline measurements before intervention

  • Time-course sampling to capture dynamic metabolic changes

  • Inclusion of appropriate controls to account for non-specific effects

  • Cross-over designs when appropriate to control for individual variation

3. Analytical approaches to demonstrate specificity:

  • Multiple assays to confirm enzymatic activity changes

  • Measurement of substrate accumulation and product formation

  • Dose-response experiments to establish causality

  • In vitro validation studies to complement in vivo findings

4. Data analysis strategies:

  • Pathway analysis to understand broader metabolic implications

  • Kinetic modeling to quantify enzymatic effects

  • Statistical approaches to isolate specific enzyme contributions from general metabolic changes

The research on hepatic triglyceride lipase in cynomolgus monkeys exemplifies this approach, with liver biopsies showing 65-90% decreased hepatic triglyceride lipase activity following antibody infusion, while analytical ultracentrifugation revealed specific changes in lipoprotein fractions, demonstrating the enzyme's role in lipoprotein metabolism .

What approaches help researchers interpret contradictory results in experimental studies?

When researchers encounter contradictory results in experimental studies, a systematic methodological approach can help resolve discrepancies and advance understanding:

1. Analytical verification:

  • Reanalyze raw data to identify potential analytical errors

  • Verify instrument calibration and measurement procedures

  • Assess statistical power and appropriateness of analytical methods

  • Examine potential outliers and their influence on results

2. Methodological comparison:

  • Identify differences in experimental protocols that might explain contradictions

  • Consider variations in study populations, sample preparation, or environmental conditions

  • Evaluate differences in reagents, antibodies, or analytical techniques

  • Assess timing differences in measurements

3. Biological interpretation frameworks:

  • Consider whether contradictions reflect actual biological variation rather than methodological issues

  • Evaluate whether conflicting results might reflect different aspects of complex biological systems

  • Develop integrated models that accommodate apparently contradictory findings

  • Identify potential moderating variables that might explain differences

4. Resolution strategies:

  • Design critical experiments specifically to test competing hypotheses

  • Conduct systematic variation of experimental conditions to identify factors driving discrepancies

  • Perform meta-analysis when multiple studies show conflicting results

  • Collaborate with laboratories reporting contradictory findings

5. Presentation approaches:

  • Report contradictory findings transparently rather than selectively reporting confirmatory results

  • Discuss limitations and alternative interpretations of data

  • Suggest specific future research directions to resolve contradictions

  • Consider multiple working hypotheses when interpreting complex data

For example, in lipoprotein metabolism research, contradictions regarding lipase activity effects on lipoprotein profiles might be addressed by examining species differences, antibody specificity, or details of ultracentrifugation methodology .

How should researchers approach informed consent in complex experimental designs?

Obtaining valid informed consent for complex experimental designs requires methodological approaches that go beyond standard consent procedures:

1. Enhanced consent materials:

  • Develop tiered information sheets with essential information highlighted

  • Create visual aids to explain complex designs (e.g., crossover, factorial, or adaptive designs)

  • Use multimedia approaches for complicated protocols when appropriate

  • Implement teach-back methods to verify understanding

2. Process adaptations for complex designs:

  • Staged consent for studies with multiple phases or decision points

  • Re-consent procedures for studies with adaptive elements

  • Extended timeframes for consideration of participation

  • Involvement of patient advocates or research subject advocates in consent development

3. Special considerations for specific designs:

Design TypeConsent Considerations
FactorialClear explanation of multiple interventions and their combinations
CrossoverDetailed description of sequence, washout periods, and carryover effects
AdaptiveExplanation of how treatment assignment may change based on emerging data
Cluster randomizedCommunity engagement and distinction between community and individual consent
Deception studiesPlan for debriefing and option to withdraw data after revelation

4. Documentation and quality assurance:

  • Structured assessment of comprehension for key protocol elements

  • Ongoing consent verification for lengthy studies

  • Documentation of consent discussions beyond signature collection

  • Regular review of consent process effectiveness

These approaches help ensure that research participants can make genuinely informed decisions about participation in complex studies while maintaining scientific validity and compliance with ethical standards .

What methodological safeguards can researchers implement to ensure compliance with international research standards?

Ensuring compliance with international research standards requires systematic methodological safeguards throughout the research process:

1. Pre-study compliance planning:

  • Comprehensive regulatory assessment across all participating countries

  • Development of a regulatory matrix identifying all applicable standards

  • Consultation with local experts and ethics committees

  • Protocol harmonization to meet the most stringent applicable requirements

  • Building flexibility into protocols to accommodate regional variations

2. Documentation and training systems:

  • Standard Operating Procedures (SOPs) aligned with international standards

  • Training programs customized for regional requirements

  • Certification verification for all research personnel

  • Translation and back-translation of critical documents

  • Cultural adaptation of research materials

3. Ongoing compliance monitoring:

  • Regular internal audits against regulatory requirements

  • Independent monitoring committees with international expertise

  • Real-time tracking of protocol deviations and corrective actions

  • Systematic documentation of compliance activities

  • Regular updates on regulatory changes

4. Ethics committee engagement:

  • Early consultation with ethics committees in all participating regions

  • Clear communication about multi-jurisdictional approvals

  • Documentation of different regional requirements and how they are addressed

  • Transparent reporting of safety events to all oversight bodies

The International Compilation of Human Research Standards provides a comprehensive resource for identifying applicable standards across 133 countries, categorizing requirements for various research types including general human subjects protections, drugs and devices research, privacy considerations, and special categories like genetic research or research with vulnerable populations .

How do researchers appropriately manage and protect human biological materials in experimental studies?

Managing human biological materials in experimental research requires sophisticated methodological approaches to ensure both scientific validity and ethical compliance:

1. Collection and processing protocols:

  • Standardized procedures for specimen acquisition, processing, and storage

  • Quality control measures to ensure sample integrity

  • Comprehensive documentation of sample handling

  • Validation of analytical methods for specific sample types

2. Ethical and legal frameworks:

  • Specific consent for biological material collection and future use

  • Clear policies on incidental findings and return of results

  • Procedures for withdrawal of consent and sample destruction

  • Compliance with jurisdiction-specific biospecimen regulations

3. Data security and privacy protection:

  • Coding systems to protect donor identity

  • Secure infrastructure for specimen storage and tracking

  • Access controls based on the principle of least privilege

  • Data encryption for associated digital information

4. Long-term management considerations:

5. Special considerations for specific material types:

Material TypeKey Methodological Considerations
Genetic samplesAdditional privacy protections; policies on secondary findings; family implications
Tissues requiring fresh processingTime-sensitive protocols; backup procedural plans; quality indicators
Rare or limited samplesPrioritization frameworks; methods minimizing sample consumption; validation with minimal material
Materials with cultural significanceCommunity engagement; respect for cultural beliefs; consultation with community representatives

Researchers working with human biological materials must navigate these methodological complexities while ensuring compliance with international standards that may vary significantly across jurisdictions .

Product Science Overview

Gene and Protein Structure

The C19orf10 gene is situated on the short arm of chromosome 19. It encodes a protein that is composed of a specific sequence of amino acids, which are the building blocks of proteins. The exact function of the C19orf10 protein is not fully understood, but it is believed to play a role in various cellular processes.

Expression and Function

The expression of the C19orf10 gene varies across different tissues in the human body. It is known to be expressed in several tissues, including the liver, kidney, and brain. The protein encoded by this gene is thought to be involved in cellular signaling pathways, although the precise mechanisms remain to be elucidated.

Recombinant Protein Production

Recombinant human C19orf10 is produced using recombinant DNA technology. This involves inserting the C19orf10 gene into a suitable expression vector, which is then introduced into a host cell, such as bacteria or yeast. The host cells are cultured under conditions that promote the expression of the C19orf10 protein. Once produced, the protein is purified from the host cells for use in various research applications.

Research Applications

Recombinant human C19orf10 is used in a variety of research studies to understand its function and role in human health and disease. It is particularly useful in studies involving protein-protein interactions, cellular signaling pathways, and the identification of potential therapeutic targets. Researchers use recombinant proteins to study the effects of specific mutations, post-translational modifications, and interactions with other cellular components.

Clinical Relevance

While the exact clinical significance of C19orf10 is still under investigation, alterations in the expression or function of this protein may be associated with certain diseases. Understanding the role of C19orf10 in disease processes could lead to the development of new diagnostic and therapeutic strategies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.